Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:collaboratedWith |
gptkb:Eli_Lilly_and_Company
gptkb:Bristol_Myers_Squibb gptkb:Zhejiang_Medicine |
| gptkbp:focusesOn |
protein therapeutics
antibody-drug conjugates |
| gptkbp:foundedYear |
2003
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:ARX788
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:AMAM
|
| gptkbp:technology |
site-specific protein conjugation
|
| gptkbp:website |
https://www.ambrx.com/
|
| gptkbp:bfsParent |
gptkb:Peter_G._Schultz
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ambrx
|